Skip to main content
Fig. 3 | Cancer Nanotechnology

Fig. 3

From: Maximizing oxaliplatin's impact on EGFR + colorectal cancer through targeted extracellular vesicles

Fig. 3

Analysis of the specific accumulation of M-C-293EVs/Rho in colorectal cancer cell lines. 2 mg/ml of 293EVs/Rho and M-C-293EVs/Rho were added to HCT116 (EGFR + , A) or SW620 (EGFR-, B) cells and incubated for 60 min. The signal intensity of rhodamine B was analyzed using confocal microscopy. The excitation/emission spectra of rhodamine were 535/595–600 nm, and the excitation/emission spectra of DAPI were 358/461 nm. 293EVs/Rho: rhodamine-loaded 293EVs. M-C-293EVs/Rho: rhodamine-loaded M-C-293EVs

Back to article page